Background and objectives: Mesenchymal stromal cells (MSCs) abrogate alloimmune response in vitro, suggesting a novel cell-based approach in transplantation. Moving this concept toward clinical application in organ transplantation should be critically assessed. Design, setting, participants & measurements: A safety and clinical feasibility study (ClinicalTrials.gov, NCT00752479) of autologous MSC infusion was conducted in two recipients of kidneys from living-related donors. Patients were given T cell - depleting induction therapy and maintenance immunosuppression with cyclosporine and mycophenolate mofetil. On day 7 posttransplant, MSCs were administered intravenously. Clinical and immunomonitoring of MSC-treated patients was performed up to day 360 postsurgery. Results: Serum creatinine levels increased 7 to 14 days after cell infusion in both MSC-treated patients. A graft biopsy in patient 2 excluded acute graft rejection, but showed a focal inflammatory infiltrate, mostly granulocytes. In patient 1 protocol biopsy at 1-year posttransplant showed a normal graft. Both MSCtreated patients are in good health with stable graft function. A progressive increase of the percentage of CD4+CD25highFoxP3+CD127- Treg and a marked inhibition of memory CD45RO+RA-CD8+ T cell expansion were observed posttransplant. Patient T cells showed a profound reduction of CD8+ T cell activity. Conclusions: Findings from this study in the two patients show that MSC infusion in kidney transplant recipients is feasible, allows enlargement of Treg in the peripheral blood, and controls memory CD8+ T cell function. Future clinical trials with MSCs to look with the greatest care for unwanted side effects is advised.
Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility / N. Perico, F. Casiraghi, M. Introna, E. Gotti, M. Todeschini, R.A. Cavinato, C. Capelli, A. Rambaldi, P. Cassis, P. Rizzo, M. Cortinovis, M. Marasà, J. Golay, M. Noris, G. Remuzzi. - In: CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. - ISSN 1555-9041. - 6:2(2011 Feb), pp. 412-422.
|Titolo:||Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility|
|Parole Chiave:||regulatory T-cells; stem-cells; allograft tolerance; thymocyte globulin; therapy; immunosupression; proliferation; induction; depletion; memory|
|Settore Scientifico Disciplinare:||Settore MED/14 - Nefrologia|
|Data di pubblicazione:||feb-2011|
|Data ahead of print / Data di stampa:||ott-2010|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.2215/CJN.04950610|
|Appare nelle tipologie:||01 - Articolo su periodico|